DK-TCIP2 is an anticancer agent formed by linking the CDK9 inhibitor SNS-032 and the BCL6 inhibitor BI-3812. This compound exhibits anticancer activity both in vivo and in vitro, making it suitable for research in lymphoma.
Molecular Weight:
1087.75
Formula:
C52H67ClN12O8S2
Target:
CDK|||Bcl-6
T201211
* VAT and and shipping costs not included. Errors and price changes excepted
